Announcements Trials
Browse Landscape

Status

Completed 8Active not recruiting 3Terminated 2Unknown 1Recruiting 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 28Breast Diseases 3Advanced Breast Cancer 2Vitamin D Deficiency 1Triple Negative Breast Neoplasms 1Recurrence 1Obesity 1Nutrition Disorders 1Neoplasms 1Neoplasm Metastasis 1Inflammatory Breast Neoplasms 1Endometrial Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma 1Camurati-Engelmann Syndrome 1Bulbo-Spinal Atrophy, X-Linked 1Breast Carcinoma In Situ 1Breast Cancer Organoids 1Arthritis 1Arthralgia 1

Interventions

Exercise 19Drug Therapy 18pembrolizumab 13Capecitabine 11Blood Specimen Collection 11Surveys and Questionnaires 10Radiotherapy 10Paclitaxel 9Dexamethasone 9Nivolumab 8Standard of Care 7Oxaliplatin 7Fluorouracil 7Erlotinib Hydrochloride 7apatinib 6Interviews as Topic 6Gemcitabine 6Control Groups 6Cisplatin 6Therapeutics 5Neoadjuvant Therapy 5Mindfulness-Based Cognitive Therapy 5Metformin 5Injections 5Everolimus 5Docetaxel 5Cyclophosphamide 5Bevacizumab 5sintilimab 4atezolizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neoplasms × Anastrozole × Clear all
NCT06341283 2024-05-10

A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

The Affiliated Hospital of Qingdao University

Unknown
200 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡